• 1.

    de Górgolas M, Casado V, Renedo G, Alen JF, Fernández Guerrero ML, 2009. Nodular lung schistosomiais lesions after chemotherapy for dysgerminoma. Am J Trop Med Hyg 81: 424427.

    • Search Google Scholar
    • Export Citation
  • 2.

    Aydin H, Doppl W, Battmann A, Bohle RM, Klör HU, 1994. Opportunistic Strongyloides stercoralis hyperinfection in lymphoma patients undergoing chemotherapy and/or radiotherapy—report of a case and review of the literature. Acta Oncol 33: 7880.

    • Search Google Scholar
    • Export Citation
  • 3.

    Wirk B, Wingard JR, 2009. Strongyloides stercoralis hyperinfection in hematopoietic stem cell transplantation. Transpl Infect Dis Off J Transplant Soc 11: 143148.

    • Search Google Scholar
    • Export Citation
  • 4.

    Eurostat, 2015. Migration and Migrant Population Statistics: Statistics Explained. Available at: http://ec.europa.eu/eurostat/statistics-explained/index.php/Migration_and_migrant_population_statistics. Accessed September 2, 2015.

    • Search Google Scholar
    • Export Citation
  • 5.

    Sección Prensa/Cifras Oficiales de Población. Explotación Estadística del Padrón. Available at: http://www.ine.es/prensa/padron_prensa.htm. Accessed August 27, 2015.

    • Search Google Scholar
    • Export Citation
  • 6.

    McDermott S, Desmeules M, Lewis R, Gold J, Payne J, Lafrance B, Vissandjée B, Kliewer E, Mao Y, 2010. Cancer incidence among Canadian immigrants, 1980–1998: results from a national cohort study. J Immigr Minor Health 13: 1526.

    • Search Google Scholar
    • Export Citation
  • 7.

    Vázquez M-L, Terraza-Núñez R, Vargas I, Rodríguez D, Lizana T, 2011. Health policies for migrant populations in three European countries: England; Italy and Spain. Health Policy Amst Neth 101: 7078.

    • Search Google Scholar
    • Export Citation
  • 8.

    Kindwall-Keller T, Isola LM, 2009. The evolution of hematopoietic SCT in myelodysplastic syndrome. Bone Marrow Transplant 43: 597609.

  • 9.

    Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, Wingard JR, Young JA, Boeckh MJ, Center for International Blood and Marrow Research, National Marrow Donor Program, European Blood and Marrow Transplant Group, American Society of Blood and Marrow Transplantation, Canadian Blood and Marrow Transplant Group, Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, Association of Medical Microbiology and Infectious Disease Canada, Centers for Disease Control and Prevention, 2009. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15: 11431238.

    • Search Google Scholar
    • Export Citation
  • 10.

    Rougemont M, Van Saanen M, Sahli R, Hinrikson HP, Bille J, Jaton K, 2004. Detection of four Plasmodium species in blood from humans by 18S rRNA gene subunit-based and species-specific real-time PCR assays. J Clin Microbiol 42: 56365643.

    • Search Google Scholar
    • Export Citation
  • 11.

    Piron M, Fisa R, Casamitjana N, López-Chejade P, Puig L, Vergés M, Gascón J, Gómez i Prat J, Portús M, Sauleda S, 2007. Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop 103: 195200.

    • Search Google Scholar
    • Export Citation
  • 12.

    Protocols Clinicos SEIMC. seimc-procedimientoclinicox.pdf. Available at: http://www.seimc.org/contenidos/documentoscientificos/procedimientosclinicos/seimc-procedimientoclinicox.pdf. Accessed September 4, 2015.

    • Search Google Scholar
    • Export Citation
  • 13.

    Khalil HM, Makled MK, Azab ME, Abdalla HM, el Sherif EA, Nassef NS, 1991. Opportunistic parasitic infections in immunocompromised hosts. J Egypt Soc Parasitol 21: 657668.

    • Search Google Scholar
    • Export Citation
  • 14.

    Graeff-Teixeira C, Leite CS, Sperhacke CL, Fassina K, Petry SM, Mucenic T, Pandolfi C, Barcellos S, Job F, 1997. Prospective study of strongyloidosis in patients with hematologic malignancies. Rev Soc Bras Med Trop 30: 355357.

    • Search Google Scholar
    • Export Citation
  • 15.

    Guarner J, Matilde-Nava T, Villaseñor-Flores R, Sanchez-Mejorada G, 1997. Frequency of intestinal parasites in adult cancer patients in Mexico. Arch Med Res 28: 219222.

    • Search Google Scholar
    • Export Citation
  • 16.

    Schaffel R, Nucci M, Portugal R, Castro MB, Ferreira SB, Almeida L, Spector N, Pulcheri W, 2000. Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies. Clin Infect Dis Off Publ Infect Dis Soc Am 31: 821822.

    • Search Google Scholar
    • Export Citation
  • 17.

    Bocanegra C, Salvador F, Sulleiro E, Sánchez-Montalvá A, Pahissa A, Molina I, 2014. Screening for imported diseases in an immigrant population: experience from a teaching hospital in Barcelona, Spain. Am J Trop Med Hyg 91: 12771281.

    • Search Google Scholar
    • Export Citation
  • 18.

    Salvador F, Sulleiro E, Sánchez-Montalvá A, Saugar JM, Rodríguez E, Pahissa A, Molina I, 2014. Usefulness of Strongyloides stercoralis serology in the management of patients with eosinophilia. Am J Trop Med Hyg 90: 830834.

    • Search Google Scholar
    • Export Citation
  • 19.

    Salvador F, Molina I, Sulleiro E, Burgos J, Curran A, Van den Eynde E, Villar del Saz S, Navarro J, Crespo M, Ocaña I, Ribera E, Falcó V, Pahissa A, 2013. Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain. Am J Trop Med Hyg 88: 11961202.

    • Search Google Scholar
    • Export Citation
  • 20.

    Schaffel R, Portugal R, Maiolino A, Nucci M, 2004. Strongyloidiasis pre and post autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 33: 117.

    • Search Google Scholar
    • Export Citation
  • 21.

    Schaffel R, Nucci M, Carvalho E, Braga M, Almeida L, Portugal R, Pulcheri W, 2001. The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies. Am J Trop Med Hyg 65: 346350.

    • Search Google Scholar
    • Export Citation
  • 22.

    Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB, 1981. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 3: 397407.

    • Search Google Scholar
    • Export Citation
  • 23.

    Portugal R, Schaffel R, Almeida L, Spector N, Nucci M, 2002. Thiabendazole for the prophylaxis of strongyloidiasis in immunosuppressed patients with hematological diseases: a randomized double-blind placebo-controlled study. Haematologica 87: 663664.

    • Search Google Scholar
    • Export Citation
  • 24.

    Machado ER, Carlos D, Sorgi CA, Ramos SG, Souza DI, Soares EG, Costa-Cruz JM, Ueta MT, Aronoff DM, Faccioli LH, 2011. Dexamethasone effects in the Strongyloides venezuelensis infection in a murine model. Am J Trop Med Hyg 84: 957966.

    • Search Google Scholar
    • Export Citation
  • 25.

    Montes M, White AC, Kontoyiannis DP, 2004. Symptoms of intestinal schistosomiasis presenting during treatment of large B cell lymphoma. Am J Trop Med Hyg 71: 552553.

    • Search Google Scholar
    • Export Citation
  • 26.

    Metze K, Lorand-Metze I, De Almeida EA, De Moraes SL, 1991. Reactivation of Chagas' myocarditis during therapy of Hodgkin's disease. Trop Geogr Med 43: 228230.

    • Search Google Scholar
    • Export Citation
  • 27.

    Altclas J, Sinagra A, Dictar M, Luna C, Verón MT, De Rissio AM, García MM, Salgueira C, Riarte A, 2005. Chagas disease in bone marrow transplantation: an approach to preemptive therapy. Bone Marrow Transplant 36: 123129.

    • Search Google Scholar
    • Export Citation
  • 28.

    Pérez-Molina JA, Perez AM, Norman FF, Monge-Maillo B, López-Vélez R, 2015. Old and new challenges in Chagas disease. The Lancet Infect Dis 15: 134756.

    • Search Google Scholar
    • Export Citation
  • 29.

    Fakhar M, Asgari Q, Motazedian MH, Monabati A, 2008. Mediterranean visceral leishmaniasis associated with acute lymphoblastic leukemia (ALL). Parasitol Res 103: 473475.

    • Search Google Scholar
    • Export Citation
  • 30.

    de Medeiros BC, de Medeiros CR, Werner B, Loddo G, Pasquini R, Bleggi-Torres LF, 2001. Disseminated toxoplasmosis after bone marrow transplantation: report of 9 cases. Transpl Infect Dis Off J Transplant Soc 3: 2428.

    • Search Google Scholar
    • Export Citation
  • 31.

    Edvinsson B, Lundquist J, Ljungman P, Ringdén O, Evengård B, 2008. A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation. APMIS 116: 345351.

    • Search Google Scholar
    • Export Citation
  • 32.

    Ashbee HR, Evans EGV, Viviani MA, Dupont B, Chryssanthou E, Surmont I, Tomsikova A, Vachkov P, Enero B, Zala J, Tintelnot K, ECMM Working Group on Histoplasmosis, 2008. Histoplasmosis in Europe: report on an epidemiological survey from the European Confederation of Medical Mycology Working Group. Med Mycol 46: 5765.

    • Search Google Scholar
    • Export Citation
  • 33.

    Adderson EE, 2004. Histoplasmosis in a pediatric oncology center. J Pediatr 144: 100106.

  • 34.

    Assi MA, Sandid MS, Baddour LM, Roberts GD, Walker RC, 2007. Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore) 86: 162169.

    • Search Google Scholar
    • Export Citation
  • 35.

    Vergidis P, Avery RK, Wheat LJ, Dotson JL, Assi MA, Antoun SA, Hamoud KA, Burdette SD, Freifeld AG, McKinsey DS, Money ME, Myint T, Andes DR, Hoey CA, Kaul DA, Dickter JK, Liebers DE, Miller RA, Muth WE, Prakash V, Steiner FT, Walker RC, Hage CA, 2015. Histoplasmosis complicating tumor necrosis factor–α blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis 61: 409417.

    • Search Google Scholar
    • Export Citation
  • 36.

    Kauffman CA, 2008. Diagnosis of histoplasmosis in immunosuppressed patients. Curr Opin Infect Dis 21: 421425.

  • 37.

    Glenn TJ, Blair JE, Adams RH, 2005. Coccidioidomycosis in hematopoietic stem cell transplant recipients. Med Mycol 43: 705710.

  • 38.

    Blair JE, Smilack JD, Caples SM, 2005. Coccidioidomycosis in patients with hematologic malignancies. Arch Intern Med 165: 113117.

 
 
 

 

 

 

 

 

 

Imported Disease Screening Prior to Chemotherapy and Bone Marrow Transplantation for Oncohematological Malignancies

View More View Less
  • 1 Infectious Disease Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • | 2 Hematological Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • | 3 Microbiology Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • | 4 Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.

Abstract

Reactivation of latent imported infections has been periodically reported in migrant patients undergoing immunosuppression. We performed a prospective study at Vall d'Hebron University Hospital (Barcelona, Spain). Migrant patients over 16 years with the diagnosis of any oncohematologic disease were included. Patients were tested for soil-transmitted helminths, hepatitis virus, and human immunodeficiency virus, Treponema pallidum, human T-cell lymphotropic virus, latent tuberculosis infection, Toxoplasma spp., Plasmodium infection, Schistosoma spp., Trypanosoma cruzi infection, Leishmania spp., and dimorphic fungi. Patients were treated and followed for 1 year to assess reactivation. A total of 42 patients were included in this study. Median age was 39 (31–51) years. Twenty-five (59.5%) patients were women. More than half of the patients were of Latin American origin. Sixteen patients (38.1%) underwent hematopoietic stem cell transplantation. Of the patients, 71.4% had at least one imported infection. Patients with at least one positive result in the screening did not show any statistically significant association with the studied variables. We did not find any reactivation of the treated latent infections. After specific treatment we did not observe any reactivation. Screening of latent imported infections previous to an immunosuppressive treatment is easy to perform and it may be lifesaving.

Author Notes

* Address correspondence to Adrián Sánchez-Montalvá, Departamento de Enfermedades Infecciosas, Hospital Universitario Vall d'Hebron, Passeig Vall d'Hebron, 119–129, Edificio General, 6ª planta, CP 08035, Barcelona, Spain. E-mail: adsanche@vhebron.net

Authors' addresses: Adrián Sánchez-Montalvá, Fernando Salvador, Isabel Ruiz-Camps, and Israel Molina, Infectious Disease Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, Barcelona, Spain, E-mails: adsanche@vhebron.net, fmsalvad@vhebron.net, iruiz@vhebron.net, and imolina@vhebron.net. Pere Barba and David Valcárcel, Hematological Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain, E-mails: pebarba@vhebron.net and dvalcarcel@vhebron.net. Elena Sulleiro, Microbiology Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, Barcelona, Spain, E-mail: esulleir@vhebron.net. Enrique Sanz-García, Medical Oncology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain, E-mail: esanz@vhebron.net.

Save